S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NYSE:TFX

Teleflex (TFX) Stock Price, News & Analysis

$206.56
-0.82 (-0.40%)
(As of 04/19/2024 ET)
Today's Range
$205.26
$208.90
50-Day Range
$206.56
$255.15
52-Week Range
$177.63
$276.43
Volume
416,411 shs
Average Volume
242,617 shs
Market Capitalization
$9.73 billion
P/E Ratio
27.43
Dividend Yield
0.66%
Price Target
$267.50

Teleflex MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
29.5% Upside
$267.50 Price Target
Short Interest
Healthy
1.89% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
1.25mentions of Teleflex in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$1.67 M Sold Last Quarter
Proj. Earnings Growth
10.71%
From $13.73 to $15.20 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.77 out of 5 stars

Medical Sector

50th out of 907 stocks

Surgical & Medical Instruments Industry

9th out of 96 stocks

TFX stock logo

About Teleflex Stock (NYSE:TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Stock Price History

TFX Stock News Headlines

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Guru Fundamental Report for TFX
TFX Mar 2024 200.000 put
Teleflex Enters Oversold Territory (TFX)
TFX Jul 2024 300.000 call
Teleflex: Dividend Insights
Decoding Teleflex Inc (TFX): A Strategic SWOT Insight
RBC Capital Reaffirms Their Buy Rating on Teleflex (TFX)
Teleflex Earnings Transcript (NYSE:TFX)
Breaking Down Teleflex: 4 Analysts Share Their Views
Q4 2023 Teleflex Inc Earnings Call
Teleflex Inc Q4 Profit Decreases, but beats estimates
Teleflex Announces Quarterly Dividend
See More Headlines
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Ex-Dividend for 3/15 Dividend
2/29/2024
Dividend Payable
3/15/2024
Today
4/21/2024
Next Earnings (Confirmed)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
CUSIP
87936910
Employees
14,500
Year Founded
1943

Price Target and Rating

Average Stock Price Target
$267.50
High Stock Price Target
$293.00
Low Stock Price Target
$225.00
Potential Upside/Downside
+29.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
10 Analysts

Profitability

Net Income
$356.33 million
Pretax Margin
14.59%

Debt

Sales & Book Value

Annual Sales
$2.97 billion
Cash Flow
$18.83 per share
Book Value
$94.49 per share

Miscellaneous

Free Float
46,427,000
Market Cap
$9.73 billion
Optionable
Optionable
Beta
1.11

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

TFX Stock Analysis - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TFX shares.
View TFX analyst ratings
or view top-rated stocks.

What is Teleflex's stock price target for 2024?

10 Wall Street analysts have issued 1 year target prices for Teleflex's stock. Their TFX share price targets range from $225.00 to $293.00. On average, they predict the company's stock price to reach $267.50 in the next year. This suggests a possible upside of 29.5% from the stock's current price.
View analysts price targets for TFX
or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2024?

Teleflex's stock was trading at $249.34 at the beginning of the year. Since then, TFX stock has decreased by 17.2% and is now trading at $206.56.
View the best growth stocks for 2024 here
.

Are investors shorting Teleflex?

Teleflex saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 817,200 shares, a decrease of 42.0% from the February 29th total of 1,410,000 shares. Based on an average daily volume of 250,100 shares, the short-interest ratio is currently 3.3 days.
View Teleflex's Short Interest
.

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our TFX earnings forecast
.

How can I listen to Teleflex's earnings call?

Teleflex will be holding an earnings conference call on Thursday, May 2nd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 609-800-9909 with passcode "69028".

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) released its earnings results on Thursday, February, 22nd. The medical technology company reported $3.38 EPS for the quarter, beating analysts' consensus estimates of $3.26 by $0.12. The medical technology company had revenue of $773.90 million for the quarter, compared to the consensus estimate of $769.01 million. Teleflex had a net margin of 11.98% and a trailing twelve-month return on equity of 14.98%. The company's revenue was up 2.1% compared to the same quarter last year. During the same quarter last year, the firm posted $3.52 EPS.
Read the conference call transcript
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, February 22nd. Stockholders of record on Friday, March 1st will be paid a dividend of $0.34 per share on Friday, March 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Thursday, February 29th.
Read our dividend analysis for TFX
.

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.66%. The dividend payout ratio is 18.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 8.95% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY24 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of $13.55-$13.95 for the period, compared to the consensus earnings per share estimate of $13.73.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

Who are Teleflex's major shareholders?

Teleflex's stock is owned by many different retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.23%), Mountain Pacific Investment Advisers Inc. ID (0.17%), Allspring Global Investments Holdings LLC (0.06%), Bridge Creek Capital Management LLC (0.03%), State of Michigan Retirement System (0.03%) and Rowlandmiller & PARTNERS.ADV (0.02%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends
.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:TFX) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners